Burning Rock Biotech (BNR) Inventory (2021 - 2023)

Burning Rock Biotech has reported Inventory over the past 3 years, most recently at $9.6 million for Q4 2023.

  • Quarterly results put Inventory at $9.6 million for Q4 2023, down 47.69% from a year ago — trailing twelve months through Dec 2023 was $9.6 million (down 47.69% YoY), and the annual figure for FY2023 was $9.7 million, down 49.92%.
  • Inventory for Q4 2023 was $9.6 million at Burning Rock Biotech, down from $18.3 million in the prior quarter.
  • Over the last five years, Inventory for BNR hit a ceiling of $19.3 million in Q4 2021 and a floor of $9.6 million in Q4 2023.
  • Median Inventory over the past 3 years was $18.3 million (2022), compared with a mean of $15.7 million.
  • Biggest five-year swings in Inventory: decreased 4.92% in 2022 and later crashed 47.69% in 2023.
  • Burning Rock Biotech's Inventory stood at $19.3 million in 2021, then decreased by 4.92% to $18.3 million in 2022, then tumbled by 47.69% to $9.6 million in 2023.
  • The last three reported values for Inventory were $9.6 million (Q4 2023), $18.3 million (Q4 2022), and $19.3 million (Q4 2021) per Business Quant data.